Founder & CEO
David previously founded an award winning hemp-based CBD company and grew it to become a market leader in Eastern Europe. David has amassed a wealth of knowledge across the medicinal cannabis space, especially in regulatory affairs. David played a key role in acquiring the first cannabis licence for CannaSVG Ltd and the first psychedelics licence for Psyched Therapeutics Ltd.
Dr. Michael Mayne
Chief Product Officer
Michael received his training in pharmacology and medicine at the University of Toronto (PhD), University of Manitoba (Post-doctoral) and National Institutes of Health in Bethesda (Fellowship). Michael has pioneered the Company’s use of MDD technology for cannabis products.
Alex Wakeford FCA
Chief Financial Officer
Alex’s previous roles include being the Finance Director at online travel agent Secret Escapes where he built the finance function to enable the company’s growth from a start-up to a £650m t/o business with c.1,000 staff over 16 countries. Alex has undertaken multiple debt, equity and M&A transactions. Before Secret Escapes Alex spent 10 years at PwC, Deloitte and Barclays Capital.
Mike Balfour OBE FCA
Mike was the founder and CEO of Fitness First which he transformed into one of the world’s largest chain of fitness clubs. Fitness First was floated on AIM in 1996 at £14m and went on to be sold to private equity in 2005 for £835m. Mike is actively involved in a number of health and healthcare related businesses.
Rory Batt MSc
Business Development & Project Manager
Rory has an MSc in Nutrition, and has conducted scientific reviews of Cannabinoid Research for conditions such as Type II Diabetes, and uses his research to develop evidence based training materials and inform product development. Rory has trained over 300 health professionals in the safe and effective use of Cannabis Based Medicines.